Related Experiment Video
Updated: Jun 1, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event
Dana Horakova1, Robert Zivadinov, Bianca Weinstock-Guttman
1Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Objectives:
The presence of MRI lesions at the first demyelinating event increases the risk of developing clinically definite multiple sclerosis (MS). The HLA DRB1*1501 genotype is linked to MS susceptibility but its relationship to quantitative MRI parameters at the first demyelinating event has not been assessed. The objectives were to assess the associations between HLA DRB1*1501 status and magnetic resonance imaging (MRI) measures in clinically isolated syndromes (CIS) at the first demyelinating event.
Methods:
We genotyped 205 CIS patients (age: 29.0±7.7 years) enrolled in the Observational Study of Early Interferon beta 1-a Treatment in High Risk Subjects after CIS (SET study), a multi-center, clinical study of CIS for rs3135005, a single nucleotide polymorphism associated with HLA DRB1*1501 status. The inclusion criteria required 2 or more brain MRI lesions and the presence of two or more oligoclonal bands in cerebrospinal fluid. Clinical and MRI assessments were obtained within 4 months of the initial demyelinating event.
Results:
The frequency of HLA DRB1*1501 positivity was 102/205 (49.7%). HLA DRB1*1501 positivity was associated with higher contrast-enhancing (CE) lesion number (p=0.002), higher CE-lesion volume (LV) (p<0.001) and exhibited a trend with higher T2-LV (p=0.012). There was no evidence for significant associations of HLA DRB1*1501 positivity with disability, symptoms at CIS presentation, whole brain, white and gray matter atrophy.
Conclusions:
HLA DRB1*1501 positivity is associated with increased brain inflammatory processes at first clinical onset. However, the effect sizes of the HLA DRB1*1501 associations with MRI are modest, which potentially limits the clinical usefulness.
Insights
The HLA DRB1*1501 genotype is linked to multiple sclerosis (MS) risk. This study found HLA DRB1*1501 positivity associated with increased inflammatory brain lesions in early MS, but clinical usefulness is limited.
Area of Science:
- Neuroimmunology
- Genetics
- Radiology
Background:
- Multiple sclerosis (MS) risk is associated with MRI lesions and HLA DRB1*1501 genotype.
- Quantitative MRI parameters at the first demyelinating event are crucial for understanding MS progression.
- The relationship between HLA DRB1*1501 and MRI measures in early MS remains unclear.
Purpose of the Study:
- To investigate the association between HLA DRB1*1501 genotype and MRI measures in patients experiencing their first demyelinating event.
- To assess if HLA DRB1*1501 status correlates with inflammatory activity and lesion load on MRI.
- To determine the potential of HLA DRB1*1501 as a biomarker for early MS disease activity.
Main Methods:
- Genotyping for rs3135005 (proxy for HLA DRB1*1501) in 205 patients with clinically isolated syndromes (CIS).
- Inclusion criteria: 2+ brain MRI lesions and oligoclonal bands in CSF.
- MRI and clinical assessments performed within 4 months of the initial demyelinating event.
Main Results:
- HLA DRB1*1501 positivity was observed in 49.7% of patients.
- HLA DRB1*1501 positivity correlated with a higher number and volume of contrast-enhancing (CE) lesions.
- A trend towards higher T2 lesion volume was noted, but no significant associations with atrophy or disability were found.
Conclusions:
- HLA DRB1*1501 positivity is linked to increased inflammatory processes in the brain at the onset of demyelination.
- The observed associations between HLA DRB1*1501 and MRI findings are modest.
- The clinical utility of HLA DRB1*1501 as a predictive marker for early MS activity requires further investigation.
Related Concept Videos
Herpes
Type I Diabetes I: Introduction
Multiple Sclerosis l: Introduction
